More about

Methotrexate

News
December 02, 2020
2 min read
Save

Methotrexate discontinuation feasible in patients with stable PsA receiving tofacitinib

Methotrexate discontinuation feasible in patients with stable PsA receiving tofacitinib

Among patients with stable psoriatic arthritis receiving tofacitinib with methotrexate, some may be able to discontinue methotrexate without changes in disease activity or safety, according to data published in The Lancet Rheumatology.

News
December 02, 2020
2 min read
Save

Evidence inconclusive for immunosuppressing drugs’ influence on men’s sexual health

Evidence inconclusive for immunosuppressing drugs’ influence on men’s sexual health

A systematic review of 161 studies showed a lack of conclusive evidence on the influence and safety of immunosuppressive drugs on male sexual health, according to a study published in Human Reproduction Update.

News
November 18, 2020
3 min read
Save

Herpes zoster more common with upadacitinib than adalimumab plus methotrexate in RA

Herpes zoster more common with upadacitinib than adalimumab plus methotrexate in RA

Among patients with rheumatoid arthritis, herpes zoster is more common in those treated with upadacitinib than with adalimumab plus methotrexate or with methotrexate alone, according to a speaker at ACR Convergence 2020.

News
November 17, 2020
3 min read
Save

Etanercept monotherapy superior to methotrexate in RA remission maintenance

Etanercept monotherapy superior to methotrexate in RA remission maintenance

In patients with rheumatoid arthritis who achieve remission with combination therapy and then withdraw either etanercept or methotrexate, monotherapy with the former is superior to the latter for remission maintenance, noted a speaker here.

News
November 11, 2020
2 min watch
Save

VIDEO: ‘The great debate’ on JAK-inhibitor use in RA at ACR 2020

VIDEO: ‘The great debate’ on JAK-inhibitor use in RA at ACR 2020

In this video, Dana DiRenzo, MD, MHS, instructor of medicine at Johns Hopkins, summarized “The Great Debate” at ACR 2020

News
November 11, 2020
2 min read
Save

Oral methotrexate linked to lower inflammation in knee OA after 3 months

Oral methotrexate linked to lower inflammation in knee OA after 3 months

Patients with primary knee osteoarthritis who received at least 3 months of oral methotrexate demonstrated significant improvement in physical function and inflammation vs. patients who received glucosamine, noted a presenter at ACR 2020.

News
November 06, 2020
3 min read
Save

Great Debate tackles when to use JAK inhibitors after methotrexate failure in RA

Great Debate tackles when to use JAK inhibitors after methotrexate failure in RA

The ACR’s annual Great Debate featured spirited arguments made for and against the use of janus kinase inhibitors before biologic therapy in the setting of methotrexate failure in rheumatoid arthritis.

News
November 06, 2020
3 min read
Save

Tuberculosis screening needed for patients receiving methotrexate in endemic areas

Tuberculosis screening needed for patients receiving methotrexate in endemic areas

Tuberculosis screening and clinical surveillance are needed for patients prescribed methotrexate — especially alongside corticosteroids or other immunosuppressants — in tuberculosis-endemic areas, according to a speaker at ACR Convergence.

News
October 10, 2020
3 min read
Save

'Newer meds' have opened the door for 'newer concepts' in treating RA

'Newer meds' have opened the door for 'newer concepts' in treating RA

While the broad range of available therapies to treat rheumatoid arthritis provides clinicians with options, there is still no clear-cut treatment algorithm for every patient, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

News
October 06, 2020
2 min read
Save

Anti-TNF, methotrexate impart 'off-target benefits' in inflammatory arthritis, diabetes

Anti-TNF, methotrexate impart 'off-target benefits' in inflammatory arthritis, diabetes

TNF inhibitors and methotrexate produced similar reductions in HbA1c among patients with psoriatic arthritis, rheumatoid arthritis or ankylosing spondylitis who also have diabetes, according to data published in BMC Rheumatology.

View more